AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
A PHASE-II WINDOW STUDY OF TOPOTECAN IN UNTREATED PATIENTS WITH HIGH-RISK ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: GORE SD ROWINSKY EK MILLER CB GRIFFIN C CHEN TL BOROWITZ M DONEHOWER RC BURKS KL ARMSTRONG DK BURKE PJ GREVER MR KAUFMANN SH
Citation: Sd. Gore et al., A PHASE-II WINDOW STUDY OF TOPOTECAN IN UNTREATED PATIENTS WITH HIGH-RISK ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Clinical cancer research, 4(11), 1998, pp. 2677-2689
HERPES-ZOSTER AND LYMPHOPENIA ASSOCIATED WITH SODIUM STIBOGLUCONATE THERAPY FOR CUTANEOUS LEISHMANIASIS
Authors: WORTMANN GW ARONSON NE BYRD JC GREVER MR OSTER CN
Citation: Gw. Wortmann et al., HERPES-ZOSTER AND LYMPHOPENIA ASSOCIATED WITH SODIUM STIBOGLUCONATE THERAPY FOR CUTANEOUS LEISHMANIASIS, Clinical infectious diseases, 27(3), 1998, pp. 509-512
INTRODUCTION - CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BYRD JC FLINN IW GREVER MR
Citation: Jc. Byrd et al., INTRODUCTION - CHRONIC LYMPHOCYTIC-LEUKEMIA, Seminars in oncology, 25(1), 1998, pp. 4-5
OLD AND NEW THERAPIES IN CHRONIC LYMPHOCYTIC-LEUKEMIA - NOW IS THE TIME FOR A REASSESSMENT OF THERAPEUTIC GOALS
Authors: BYRD JC RAI KR SAUSVILLE EA GREVER MR
Citation: Jc. Byrd et al., OLD AND NEW THERAPIES IN CHRONIC LYMPHOCYTIC-LEUKEMIA - NOW IS THE TIME FOR A REASSESSMENT OF THERAPEUTIC GOALS, Seminars in oncology, 25(1), 1998, pp. 65-74
TUMOR-GROWTH INHIBITION INDUCED IN A MURINE MODEL OF HUMAN BURKITTS-LYMPHOMA BY A PROTEASOME INHIBITOR
Authors: ORLOWSKI RZ ESWARA JR LAFONDWALKER A GREVER MR ORLOWSKI M DANG CV
Citation: Rz. Orlowski et al., TUMOR-GROWTH INHIBITION INDUCED IN A MURINE MODEL OF HUMAN BURKITTS-LYMPHOMA BY A PROTEASOME INHIBITOR, Cancer research, 58(19), 1998, pp. 4342-4348
FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53
Authors: BYRD JC SHINN C WASELENKO JK FUCHS EJ LEHMAN TA NGUYEN PL FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53, Blood, 92(10), 1998, pp. 3804-3816
A PHASE-II SOUTHWEST-ONCOLOGY-GROUP STUDY OF CISPLATIN AND CONTINUOUS-INFUSION VINBLASTINE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA
Authors: KEOHAN ML GREVER MR BALCERZAK SP ANTMAN K
Citation: Ml. Keohan et al., A PHASE-II SOUTHWEST-ONCOLOGY-GROUP STUDY OF CISPLATIN AND CONTINUOUS-INFUSION VINBLASTINE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA, Investigational new drugs, 15(3), 1997, pp. 255-256
FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS MARKED IN-VITRO ACTIVITY AGAINST BOTH THE K-562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS
Authors: BYRD JC WASELENKO JK SHINN CA MILLER C GORE S SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS MARKED IN-VITRO ACTIVITY AGAINST BOTH THE K-562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3810-3810
UCN-01 HAS SIGNIFICANT IN-VITRO ACTIVITY IN BOTH THE RESISTANT K562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS
Authors: SHINN CA BYRD JC WASELENKO JK SAUSVILLE E MILLER C GORE S GREVER MR
Citation: Ca. Shinn et al., UCN-01 HAS SIGNIFICANT IN-VITRO ACTIVITY IN BOTH THE RESISTANT K562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3848-3848
FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST THE K-562 CELL-LINEAND HUMAN ACUTE-LEUKEMIA CELLS
Authors: WASELENKO JK BYRD JC SHINN CA MILLER C GORE S SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST THE K-562 CELL-LINEAND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3858-3858
UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS
Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 4125-4125
CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO
Authors: WASELENKO JK BYRD JC SHINN CA FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO, Blood, 90(10), 1997, pp. 4147-4147
GEMCITABINE DEMONSTRATES SIGNIFICANT IN-VITRO ACTIVITY IN HEAVILY PRETREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: WASELENKO JK GREVER MR SHINN CA FLINN IW DIEHL LF BYRD JC
Citation: Jk. Waselenko et al., GEMCITABINE DEMONSTRATES SIGNIFICANT IN-VITRO ACTIVITY IN HEAVILY PRETREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 4148-4148
FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS
Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FUCHS E FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 2366-2366
FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: BYRD JC WASELENKO JK SHINN CA BEDI A FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2367-2367
FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION
Authors: WASELENKO JK PRZYGODZKI R GREVER MR SHINN CA SAUSVILLE E BYRD JC
Citation: Jk. Waselenko et al., FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION, Blood, 90(10), 1997, pp. 2369-2369
CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FLINN IW GREVER MR
Citation: Iw. Flinn et Mr. Grever, CHRONIC LYMPHOCYTIC-LEUKEMIA, Cancer treatment reviews, 22(1), 1996, pp. 1-13
FLUDARABINE AND CYCLOPHOSPHAMIDE AS FIRST THERAPY FOR INDOLENT LYMPHOPROLIFERATIVE DISORDERS - RESPONSE RATES AND TOXICITY
Authors: FLINN IW BYRD JC SEIFTER E MARCELLUS D LEE N DIEHL LF AMBINDER RF GREVER MR VOGELSANG G
Citation: Iw. Flinn et al., FLUDARABINE AND CYCLOPHOSPHAMIDE AS FIRST THERAPY FOR INDOLENT LYMPHOPROLIFERATIVE DISORDERS - RESPONSE RATES AND TOXICITY, Blood, 88(10), 1996, pp. 2345-2345
JASPLAKINOLIDES INHIBITION OF THE GROWTH OF PROSTATE CARCINOMA-CELLS IN-VITRO WITH DISRUPTION OF THE ACTIN CYTOSKELETON
Authors: SENDEROWICZ AMJ KAUR G SAINZ E LAING C INMAN WD RODRIGUEZ J CREWS P MALSPEIS L GREVER MR SAUSVILLE EA DUNCAN KLK
Citation: Amj. Senderowicz et al., JASPLAKINOLIDES INHIBITION OF THE GROWTH OF PROSTATE CARCINOMA-CELLS IN-VITRO WITH DISRUPTION OF THE ACTIN CYTOSKELETON, Journal of the National Cancer Institute, 87(1), 1995, pp. 46-51
PRECLINICAL PHARMACOLOGICAL EVALUATION OF GELDANAMYCIN AS AN ANTITUMOR AGENT
Authors: SUPKO JG HICKMAN RL GREVER MR MALSPEIS L
Citation: Jg. Supko et al., PRECLINICAL PHARMACOLOGICAL EVALUATION OF GELDANAMYCIN AS AN ANTITUMOR AGENT, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 305-315
PHARMACEUTICAL PROSPECTING AND THE POTENTIAL FOR PHARMACEUTICAL CROPS, NATURAL PRODUCT DRUG DISCOVERY AND DEVELOPMENT AT THE UNITED-STATES NATIONAL-CANCER-INSTITUTE
Authors: CRAGG GM BOYD MR GREVER MR SCHEPARTZ S
Citation: Gm. Cragg et al., PHARMACEUTICAL PROSPECTING AND THE POTENTIAL FOR PHARMACEUTICAL CROPS, NATURAL PRODUCT DRUG DISCOVERY AND DEVELOPMENT AT THE UNITED-STATES NATIONAL-CANCER-INSTITUTE, Annals of the Missouri Botanical Garden, 82(1), 1995, pp. 47-53
IN-VIVO CULTIVATION OF TUMOR-CELLS IN HOLLOW FIBERS
Authors: HOLLINGSHEAD MG ALLEY MC CAMALIER RF ABBOTT BJ MAYO JG MALSPEIS L GREVER MR
Citation: Mg. Hollingshead et al., IN-VIVO CULTIVATION OF TUMOR-CELLS IN HOLLOW FIBERS, Life sciences, 57(2), 1995, pp. 131-141
EFFICACY OF THE QUINOCARMYCINS KW2152 AND DX-52-1 AGAINST HUMAN-MELANOMA LINES GROWING IN CULTURE AND IN MICE
Authors: PLOWMAN J DYKES DJ NARAYANAN VL ABBOTT BJ SAITO H HIRATA T GREVER MR
Citation: J. Plowman et al., EFFICACY OF THE QUINOCARMYCINS KW2152 AND DX-52-1 AGAINST HUMAN-MELANOMA LINES GROWING IN CULTURE AND IN MICE, Cancer research, 55(4), 1995, pp. 862-867
TYRPHOSTIN AG17, I-TERT-BUTYL-4-HYDROXYBENZYLIDENE)-MALONONITRILE], INHIBITS CELL-GROWTH BY DISRUPTING MITOCHONDRIA
Authors: BURGER AM KAUR G ALLEY MC SUPKO JG MALSPEIS L GREVER MR SAUSVILLE EA
Citation: Am. Burger et al., TYRPHOSTIN AG17, I-TERT-BUTYL-4-HYDROXYBENZYLIDENE)-MALONONITRILE], INHIBITS CELL-GROWTH BY DISRUPTING MITOCHONDRIA, Cancer research, 55(13), 1995, pp. 2794-2799
UCN-01 - A NEW POTENTIAL THERAPEUTIC AGENT FOR CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: GREVER MR SHINN C LEVY J
Citation: Mr. Grever et al., UCN-01 - A NEW POTENTIAL THERAPEUTIC AGENT FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 1383-1383
Risultati: 1-25 | 26-36